A recent study provided a mechanism by which glucocorticoids may induce metastatic breast cancer and demonstrated that synthetic glucocorticoids such as DEX increased the expression of ROR1, resulting in enhanced metastasis and decreased survival in preclinical models9. The gene discussed is ROR1; the disease is breast cancer.